Compare NVCR & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVCR | ADUS |
|---|---|---|
| Founded | 2000 | 1979 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.1B |
| IPO Year | 2015 | 2009 |
| Metric | NVCR | ADUS |
|---|---|---|
| Price | $13.48 | $110.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | $28.42 | ★ $138.73 |
| AVG Volume (30 Days) | ★ 1.8M | 160.3K |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | N/A | ★ 4.66 |
| Revenue | $642,269,000.00 | ★ $1,346,596,000.00 |
| Revenue This Year | $9.75 | $25.50 |
| Revenue Next Year | $5.62 | $7.11 |
| P/E Ratio | ★ N/A | $23.83 |
| Revenue Growth | 11.17 | ★ 18.77 |
| 52 Week Low | $10.70 | $88.96 |
| 52 Week High | $32.06 | $136.72 |
| Indicator | NVCR | ADUS |
|---|---|---|
| Relative Strength Index (RSI) | 59.44 | 41.18 |
| Support Level | $12.30 | $110.12 |
| Resistance Level | $13.97 | $113.92 |
| Average True Range (ATR) | 0.55 | 2.51 |
| MACD | 0.09 | -0.39 |
| Stochastic Oscillator | 77.21 | 8.88 |
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.